全球细胞重编程市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

全球细胞重编程市场需求预计将从 2022 年的 364.95 万美元达到 2030 年近 738.47 万美元的市场规模，2023-2030 年研究期间CAGR为 9.21%。

细胞重编程是指将成熟或特化细胞的身份或特性改变回特化程度较低的状态，通常是多能或干细胞样状态的过程。这个过程需要修改细胞的基因表现模式并重新编程其命运，使其能够恢復分化为各种细胞类型的能力。

市场动态：

细胞重编程市场的成长是由生物医学创新前沿的多种因素所推动的。再生医学的进步以及诱导多能干细胞 (iPSC) 产生用于组织再生的各种细胞类型的潜力推动了市场的扩张。慢性病发病率的增加促进了对源自重编程细胞的个人化细胞疗法的需求，为心血管疾病、神经退化性疾病和糖尿病等疾病提供潜在的治疗方法。此外，细胞重编程有助于使用患者特异性细胞创建疾病模型，有助于药物开发和筛选。不断的技术进步，包括改进的重编程技术和基因组编辑工具，提高了精确度和效率，并扩大了细胞重编程的应用。产业参与者、政府资助和不断发展的监管框架之间的合作进一步塑造了市场，影响研究、创新和商业化工作。这些共同因素强调了细胞重编程在推广再生医学、疾病理解和个人化治疗方面的重要性，并有望对生物医学研究和医疗保健产生重大影响。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球细胞重编程市场的每个细分市场进行了包容性评估。细胞重编程产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲细胞重编程市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。细胞重编程市场的主要参与者包括 Thermo Fisher Scientific, Inc.、Allele Biotech、Alstem、Stemcell Technologies Inc.、Merck KGaA、Bio-Techne、REPROCELL、Lonza、FUJIFILM Corp. (Fujifilm Cellular Dynamics)、Mogrify Ltd.。这部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：细胞重编程 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按技术分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球细胞重编程市场分析：依技术分类

• 依技术概述
• 历史和预测数据
• 依技术分析
• 基于仙台病毒的重编程
• mRNA重编程
• 游离重编程
• 其他的

第 6 章：全球细胞重编程市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 研究
• 治疗性

第 7 章：全球细胞重编程市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 研究与学术机构
• 生技与製药公司

第 8 章：全球细胞重编程市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：细胞重编程公司的竞争格局

• 细胞重编程市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Thermo Fisher Scientific Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Allele Biotech
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Alstem
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Stemcell Technologies Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck KGaA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bio-Techne
• 公司简介
• 公司收入
• 产品
• 最近的发展
• REPROCELL
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Lonza
• 公司简介
• 公司收入
• 产品
• 最近的发展
• FUJIFILM Corp. (Fujifilm Cellular Dynamics)
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Mogrify Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Cell Reprogramming Market is presumed to reach the market size of nearly USD 738.47 MN by 2030 from USD 364.95 MN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.

Cell reprogramming refers to the process of changing the identity or properties of a mature or specialized cell back to a less specialized state, typically to a pluripotent or stem cell-like state. This procedure entails modifying the gene expression patterns of a cell and reprogramming its destiny, enabling it to recover the capability to differentiate into various cell types.

MARKET DYNAMICS:

The Cell reprogramming market's growth is driven by diverse factors at the forefront of biomedical innovation. Advances in regenerative medicine and the potential of induced pluripotent stem cells (iPSCs) to generate various cell types for tissue regeneration propel market expansion. The increasing incidence of chronic diseases fosters demand for personalized cell-based therapies derived from reprogrammed cells, offering potential treatments for conditions like cardiovascular diseases, neurodegenerative disorders, and diabetes. Moreover, cell reprogramming facilitates the creation of disease models using patient-specific cells, aiding drug development and screening. Ongoing technological advancements, including improved reprogramming techniques and genome editing tools, enhance precision and efficiency, widening the applications of cell reprogramming. Collaborations between industry players, government funding, and evolving regulatory frameworks further shape the market, influencing research, innovation, and commercialization efforts. These collective factors underscore the significance of cell reprogramming in advancing regenerative medicine, disease understanding, and personalized therapies, promising substantial impact in biomedical research and healthcare.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell reprogramming. The growth and trends of cell reprogramming industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell reprogramming market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

• Sendai Virus-Based Reprogramming
• mRNA Reprogramming
• Episomal Reprogramming
• Others

By Application

• Research
• Therapeutic

By End-Use

• Research & Academic Institutes
• Biotechnology & Pharmaceutical Companies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Reprogramming market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Reprogramming market include Thermo Fisher Scientific, Inc., Allele Biotech, Alstem, Stemcell Technologies Inc., Merck KGaA, Bio-Techne, REPROCELL, Lonza, FUJIFILM Corp. (Fujifilm Cellular Dynamics), Mogrify Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CELL REPROGRAMMING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY TECHNOLOGY

• 5.1 Overview by Technology
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Technology
• 5.4 Sendai Virus-based Reprogramming Historic and Forecast Sales by Regions
• 5.5 mRNA Reprogramming Historic and Forecast Sales by Regions
• 5.6 Episomal Reprogramming Historic and Forecast Sales by Regions
• 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Research Historic and Forecast Sales by Regions
• 6.5 Therapeutic Historic and Forecast Sales by Regions

7 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Research & Academic Institutes Historic and Forecast Sales by Regions
• 7.5 Biotechnology & Pharmaceutical Companies Historic and Forecast Sales by Regions

8 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CELL REPROGRAMMING COMPANIES

• 9.1. Cell Reprogramming Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF CELL REPROGRAMMING INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Thermo Fisher Scientific Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Allele Biotech
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Alstem
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Stemcell Technologies Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Merck KGaA
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Bio-Techne
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. REPROCELL
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Lonza
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. FUJIFILM Corp. (Fujifilm Cellular Dynamics)
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Mogrify Ltd.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Technology (USD MN)
• Sendai Virus-based Reprogramming Market Sales by Geography (USD MN)
• mRNA Reprogramming Market Sales by Geography (USD MN)
• Episomal Reprogramming Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Research Market Sales by Geography (USD MN)
• Therapeutic Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Research & Academic Institutes Market Sales by Geography (USD MN)
• Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
• Global Cell Reprogramming Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cell Reprogramming Report
• Market Research Process
• Market Research Methodology
• Global Cell Reprogramming Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Technology (USD MN)
• Sendai Virus-based Reprogramming Market Sales by Geography (USD MN)
• mRNA Reprogramming Market Sales by Geography (USD MN)
• Episomal Reprogramming Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Research Market Sales by Geography (USD MN)
• Therapeutic Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Research & Academic Institutes Market Sales by Geography (USD MN)
• Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.